A Study to Establish the Safety and Tolerability of Zimura™ (Anti-C5 Aptamer) in Combination with Anti-VEGF Therapy in Subjects with Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)

Trial Identifier: OPH2002
Sponsor: Ophthotech Corporation
Start Date: March 2015
Primary Completion Date: October 2015
Study Completion Date: October 2015

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
USA, AZ Pheonix, AZ, USA, 85014